Quick Overview: By testing biomarkers, doctors can better Carol Aghajanian, MD, from the Memorial Sloan-Kettering Maurie Markman, MD, president of medicine and science,
Ovarian Cancer Understanding Treatment Endpoints - Detailed Overview & Context
By testing biomarkers, doctors can better Carol Aghajanian, MD, from the Memorial Sloan-Kettering Maurie Markman, MD, president of medicine and science, Bradley Monk, MD, gynecologic oncologist, University of Arizona ... Scientific Symposium, Kathleen Moore, MD, MS, of the University of Oklahoma discusses hereditary Robert L. Coleman, MD, discusses how to interpret a patient's response to
Katherine Mager, MD, FACOG, sits down to explain what recurrent
